Stay updated on Itacitinib Combinations in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Itacitinib Combinations in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Itacitinib Combinations in Advanced Solid Tumors Clinical Trial page
- Check3 days agoChange DetectedStudy Details page appears visually refreshed with the same content and sections as before; no new or removed information or functional changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check10 days agoNo Change Detected
- Check31 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference5%

- Check39 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0, indicating a newer release.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision updated to v3.0.2 replacing v3.0.1. The 'Back to Top' link was removed.SummaryDifference0.3%

- Check60 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.3%

- Check67 days agoChange DetectedThe web page has updated its facility name and location details, while also adding new drug names such as parsaclisib, epacadostat, INCB039110, and itacitinib. The revision number has changed from v2.16.12 to v3.0.0.SummaryDifference1%

Stay in the know with updates to Itacitinib Combinations in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Itacitinib Combinations in Advanced Solid Tumors Clinical Trial page.